1 minute read

Light Therapy for Autoimmune Symptoms

Fatigue is often reported as the most disabling symptom for people with autoimmune disorders, significantly impairing their physical, mental and social quality of life. Autoimmune researchers in Denmark, noting previous studies wherein bright light therapy significantly reduced fatigue related to traumatic brain injury and cancer, devised a study involving multiple sclerosis (MS) patients. The study was conducted as a randomized, sham-controlled trial of 26 people with MS that reported a Fatigue Severity Scale (FSS) score greater than 36. Participants received either bright light therapy or a dim red light sham intervention for 30 minutes each morning for two weeks. The bright light therapy decreased FSS scores over the course of the study. However, this benefit occurred in the sham control group as well, highlighting the need for more research on the effects of light therapy on fatigue.

Reversing Type 2 Diabetes With Diet

A Type 2 diabetes (T2D) diagnosis is often regarded as a lifelong sentence and typically treated as such, requiring an increasing number of drugs. However, sustained remission of T2D is now well established.

In a recent primary care-based cohort study published in BMJ Nutrition, Prevention & Health, advice on a lowercarbohydrate diet and weight loss protocols was offered routinely to 9,800 patients with T2D between 2013 and 2021. Overall, remission was achieved in 51 percent of the patients that adopted a low-carb lifestyle, with individuals diagnosed with T2D within the previous year more likely to achieve remission (77 percent) than those that had been diagnosed for longer (20 percent for patients with a T2D duration greater than 15 years). Additionally, about 97 percent of the patients experienced improvements in blood glycemic control. Average low-density lipoprotein cholesterol and systolic blood pressure decreased, and there were also significant financial savings on drugs.

A low-carb diet may give hope to those with T2D as a practical, manageable way to achieve remission, as well as substantial health and financial benefits. Even for those with poorly controlled T2D that may not achieve remission, improvements in diabetic control may be within reach.

This article is from: